Influence of drugs on laboratory results of blood tests: a biomedical look
DOI:
https://doi.org/10.33448/rsd-v11i8.30508Keywords:
Drugs; Clinical Laboratory Techniques; Hematologic Tests; Health teaching.Abstract
Within current clinical practice, the concomitant association of multiple drugs for the treatment of chronic pathologies is a common procedure in the therapeutic drug experience. In which the complex and diverse clinical laboratory routine can be influenced by the existence of drug interference. From this perspective, through a bibliographic research of the integrative review type in the databases of the Virtual Health Library, using the insertion of the DeCS: Pharmaceutical Preparations/Pharmaceutical Preparations, Drugs, (Hematological test), combined with the help of the Boolean operator "AND", the present study sought to describe, based on the current literature, the laboratory changes caused by the use of medicines in the results of blood tests of patients. From the interpretation of the data, synthesized by the review, it was observed that the three drugs with the highest numbers of repressions in the results of blood test parameters were Methylphenidate, Capecitabine and Clozapine. Therefore, during clinical practice, biomedical professionals become fundamental pieces for carrying out an adequate analysis of changes in biochemical markers caused by medications.
References
Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). (2013). Conceitos Técnicos. Brasília, DF. http://www.anvisa.gov.br/medicamentos/conceito.htm#1.2.
Charach, G., Karniel, E., Grosskopf, I., Rabinovich, A., & Charach, L. (2020). Methylphenidate has mild hyperglycemic and hypokalemia effects and increases leukocyte and neutrophil counts. Medicine, 99(27), Artigo e20931. https://doi.org/10.1097/md.0000000000020931
Donnelly, L. A., Dennis, J. M., Coleman, R. L., Sattar, N., Hattersley, A. T., Holman, R. R., & Pearson, E. R. (2020). Risk of anemia with metformin use in type 2 diabetes: A MASTERMIND study. Diabetes Care, 43(10), 2493–2499. https://doi.org/10.2337/dc20-1104
Ferreira, B., Santos, K., Rudolph, S., Alcanfor, J., & Cunha, L. (2009). Estudo dos medicamentos utilizados pelos pacientes atendidos em laboratório de análises clínicas e suas interferências em testes laboratoriais: Uma revisão da literatura. Revista Eletrônica de Farmácia, 6(1). https://doi.org/10.5216/ref.v6i1.5859
Freitas, A. V., Freitas, M. V., Oliveira, C. G. A., Oliveira, W. D., Kashima, Y. M. P., & Barreto, J. G. (2018). Estudo da variabilidade de bilirrubina total e direta expostas à luz ambiente. Acta Biomédica Brasiliensia, 9(3), 72. https://doi.org/10.18571/acbm.187
Gharab, K. M., Onmaz, D. E., Abusoglu, S., Aydin, M., Sivrikaya, A., Tok, O., Abusoglu, G., & Unlu, A. (2020). The relationship between serum clozapine concentrations and hematological parameters by a validated mass spectrometric method. Journal of Pharmaceutical and Biomedical Analysis, 180, 113056. https://doi.org/10.1016/j.jpba.2019.113056
Junqueira, D. R. G. (2012). Desafios metodológicos em epidemiologia: uma abordagem com foco na reação adversa da trombocitopenia induzida por heparina e na condição clínica da dor lombar. [Tese de Doutorado, Universidade Federal de Minas Gerais].
Kortekaas-Rijlaarsdam, A. F., Luman, M., Sonuga-Barke, E., & Oosterlaan, J. (2018). Does methylphenidate improve academic performance? A systematic review and meta-analysis. European Child & Adolescent Psychiatry, 28(2), 155–164. https://doi.org/10.1007/s00787-018-1106-3
Leitoles, P. J. N. C., Lenhardt, M. M., Silva, B. K. F., & Tenfen, A. (2021). Interações fisiológicas causadas por medicamentos em exames bioquímicos de perfil renal e hepático/ physiological interactions caused by drugs in biochemical tests of renal and hepatic profile. Brazilian Journal of Development, 7(1), 10329–10348. https://doi.org/10.34117/bjdv7n1-702
Maduell, F., Belmar, L., Ugalde, J., Laguno, M., Martínez-Rebollar, M., Ojeda, R., Arias, M., Rodas, L., Rossi, F., Llovet, L.-P., González, L. N., Mallolas, J., & Londoño, M.-C. (2019). Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia. Gastroenterología y Hepatología (English Edition), 42(3), 164–170. https://doi.org/10.1016/j.gastre.2019.02.029
Marquito, A. B., Fernandes, N. M. S., Colugnati, F. A. B., & Paula, R. B. (2014). Identifying potential drug interactions in chronic kidney disease patients. Jornal Brasileiro de Nefrologia, 36(1), 26–34. https://doi.org/10.5935/0101-2800.20140006
Mijovic, A., & MacCabe, J. H. (2020). Clozapine-induced agranulocytosis. Annals of Hematology, 99(11), 2477–2482. https://doi.org/10.1007/s00277-020-04215-y
Ocanto, A., Debén, B., Rodríguez, I., Belinchón, B., Glaría, L., & Morera, R. (2020). Relación entre marcadores hematológicos y la respuesta patológica completa al tratamiento neoadyuvante en cáncer de recto localmente avanzado. Journal of Negative and No Positive Results, 5(11), 1356-1366.
Önder, S., & Ozturk, M. (2019). How does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria? Cutaneous and Ocular Toxicology, 39(1), 31–35. https://doi.org/10.1080/15569527.2019.1684316
Pereira, J. P.,Faustino, S. M. M.; RODRIGUES, A. S. N. (2011). Análise dos problemas encontrados na execução do coagulograma em laboratórios da cidade de Macapá-Amapá. Ciência equatorial, 1(1).
Phukan, A., Mandal, P. K., & Dolai, T. K. (2020). Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: Sharing experience of a hemato-oncology center from eastern India. Annals of Hematology, 100(1), 85–96. https://doi.org/10.1007/s00277-020-04289-8
Santos, S. L. F. d., Borges, R. N., & Barros, K. B. N. T. (2018). Drugs that interfere with the results of laboratory tests: An integrative review of the literature. Revista Brasileira de Análises Clínicas, 50(2). https://doi.org/10.21877/2448-3877.201800581
Siddiqui, N. S., Godara, A., Byrne, M. M., & Saif, M. W. (2019). Capecitabine for the treatment of pancreatic cancer. Expert Opinion on Pharmacotherapy, 20(4), 399–409. https://doi.org/10.1080/14656566.2018.1560422
Silva, R. S., Domingueti, C. P., Tinoco, M. S., Veloso, J. C., Pereira, M. L., Baldoni, A. O., & Rios, D. R. (2021). Interferência dos medicamentos nos exames laboratoriais. Jornal Brasileiro de Patologia e Medicina Laboratorial, 57.
Silva, N. A. T., Marcolino, K. G. A., Frade, R. I., & Alves, F. (2020). Análise Comparativa das Principais Alterações Hematológicas e Renais em Pacientes Adultos com Câncer Metastático Submetidos À Poliquimioterapia. NBC-Periódico Científico do Núcleo de Biociências, 10(20).
Souza, M. T., Silva, M. D., & Carvalho, R. (2010). Integrative review: What is it? How to do it? Einstein (São Paulo), 8(1), 102–106. https://doi.org/10.1590/s1679-45082010rw1134
Tamer, F. (2020). Omalizumab does not lead to a distinct alteration in hematological parameters and complete blood count-derived inflammation biomarkers except for basophil count. Cutaneous and Ocular Toxicology, 39(3), 229–232. https://doi.org/10.1080/15569527.2020.1766483
Wiciński, M., & Węclewicz, M. M. (2018). Clozapine-induced agranulocytosis/granulocytopenia. Current Opinion in Hematology, 25(1), 22–28. https://doi.org/10.1097/moh.0000000000000391
Zonozi, R., Wallace, Z. S., Laliberte, K., Huizenga, N. R., Rosenthal, J. M., Rhee, E. P., Cortazar, F. B., & Niles, J. L. (2020). Incidence, Clinical Features, and Outcomes of Late‐Onset Neutropenia From Rituximab for Autoimmune Disease. 27(2), 347–354. https://doi.org/10.1002/art.41501
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Maria Vanessa de Melo Pacheco ; Moises Thiago de Souza Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
